세계의 연어 칼시토닌 시장 : 제품 유형별, 유통 채널별, 지역별, 범위 및 전망

Calcitonin Salmon Market Size And Forecast

Calcitonin Salmon Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2024 to 2031.

The global Calcitonin Salmon Market is driven by rising number of osteoporosis patients globally. According to the International Osteoporosis Foundation, over 8.9 million people suffer from osteoporosis globally each year. The Global Calcitonin Salmon Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Calcitonin Salmon Market Definition

Calcitonin, also called thyrocalcitonin, is a linear polypeptide hormone produced in human thyroid glands by parafollicular cells. In birds, fish, and other non-mammalian animals, calcitonin is produced by cells of ultimobranchial body. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts. The potency of calcitonin salmon per mg is greater and has longer duration of action than calcitonin produced by mammalian origin.

Calcitonin salmon is produced either by synthetic processes or by microbial processes using recombinant DNA technology. Calcitonin salmon is available in two forms: injection and nasal. Fortical and Miacalcin are commonly available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Calcitonin Salmon Market Overview

The global Calcitonin Salmon Market is driven by rising number of osteoporosis patients globally. According to the International Osteoporosis Foundation, over 8.9 million people suffer from osteoporosis globally each year. Osteoporosis is more dominant in women than men and is common in geriatric population. The International Osteoporosis Foundation study reveals that over 200 million women are affected by osteoporosis globally. The FDA advisory committee has recommended preventing use of calcitonin salmon for the treatment of postmenstrual osteoporosis in women as there exists a potential risk of cancer development.

Moreover, calcitonin salmon is used as second line of treatment for osteoporosis. Side effects of calcitonin salmon are likely to be key restraints of the global market. Large number of people is not aware about having osteoporosis until they have first fracture and also Paget's disease is not common in people. These factors hamper the growth of the Calcitonin Salmon Market. Easy availability of other medications for the first line treatment of osteoporosis and related diseases is likely to restrain the market. The FDA advisory committee has suggested to companies developing new calcitonin salmon products to prove its effectiveness in reducing bone fractures. This is expected to boost the market.

Aging of populations worldwide is the major reason for the rise in the incidence of osteoporosis. Osteoporosis is reported as a serious public health concern, owing to its high prevalence worldwide. At present, it is estimated that over 200 million people globally suffer from osteoporosis. In addition, calcitonin salmon's approval for the prevention of postmenopausal and other treatment to uplift the demand in growth in the future. Lack of awareness in rural areas about osteoporosis and other bone disorder is hindering the growth of Calcitonin Salmon Market.

Furthermore, adverse effects caused due to prolong use are hampering the growth of the Calcitonin Salmon Market. It has been found that prolonged use rises the risk for cancer, attributed to this Committee for Medicinal Products for Human Use recommended that calcitonin salmon should be prescribed for two weeks with a maximum duration of four weeks for prevention of acute bone loss due to sudden immobilization.

Global Calcitonin Salmon Market Segmentation Analysis

The Global Calcitonin Salmon Market is Segmented On The Basis Of Product Type, Distribution Channel, and Geography.

Calcitonin Salmon Market, By Product Type

• Calcitonin Salmon Nasal Spray
• Calcitonin Salmon Injection

Based on Product Type, the market is segmented into Calcitonin Salmon Nasal Spray, Calcitonin Salmon Injection. Calcitonin salmon is produced either by synthetic processes or by microbial processes using recombinant DNA technology. Calcitonin salmon is available in two forms: injection and nasal. Miacalcin and Fortical are commonly available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases.

Calcitonin Salmon Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Based on Distribution Channel, the market is bifurcated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts.

Calcitonin Salmon Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Calcitonin Salmon Market is classified into North America, Europe, Asia Pacific, and Rest of the world. Prevalence of osteoporosis is higher in Middle East & Africa than in countries in the West. This is expected to propel the Calcitonin Salmon Market in this region. Increasing geriatric population with bone related diseases is likely to fuel the growth of the market in Asia Pacific during the forecast period.

• Key Players In Calcitonin Salmon Market
• The "Global Calcitonin Salmon Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
• Novartis, Sanofi, Mylan Pharmaceuticals, Apotex, Upsher-Smith Laboratories, Ferring Pharmaceuticals, Par Pharmaceutical, Torrent, Sun Pharmaceutical, United Biotech (P) Limited. and Shanghai Soho-Yiming Pharmaceuticals.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• Global Calcitonin Salmon Market

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CALCITONIN SALMON MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CALCITONIN SALMON MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CALCITONIN SALMON MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Calcitonin Salmon Nasal Spray
• 5.3 Calcitonin Salmon Injection

6 GLOBAL CALCITONIN SALMON MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
• 6.2 Hospital Pharmacies
• 6.3 Retail Pharmacies
• 6.4 Online Pharmacies

7 GLOBAL CALCITONIN SALMON MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East

8 GLOBAL CALCITONIN SALMON MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Novartis
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Sanofi
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Mylan Pharmaceuticals
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Apotex
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Upsher-Smith Laboratories
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Ferring Pharmaceuticals
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Par Pharmaceutical
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Torrent
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Sun Pharmaceutical
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Shanghai Soho-Yiming Pharmaceuticals
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research